GRK2 expression levels appear to determine the benefcial outcome of AAV9-mediated βARKct gene therapy in diferent mouse models of inherited cardiomyopathy

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions